These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 21676369)

  • 1. High-sensitivity troponin T level and angiographic severity of coronary artery disease.
    Ndrepepa G; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A
    Am J Cardiol; 2011 Sep; 108(5):639-43. PubMed ID: 21676369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epicardial fat thickness in stable coronary artery disease: its relationship with high-sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide.
    Börekçi A; Gür M; Özaltun B; Baykan AO; Harbalioğlu H; Seker T; Sen Ö; Acele A; Gözükara MY; Kuloğlu O; Koç M; Çayli M
    Coron Artery Dis; 2014 Dec; 25(8):685-90. PubMed ID: 25004239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
    Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
    Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity cardiac troponin T level is associated with angiographic complexity of coronary artery disease: a cross-sectional study.
    Yamazaki K; Iijima R; Nakamura M; Sugi K
    Heart Vessels; 2016 Jun; 31(6):890-6. PubMed ID: 25964074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T.
    Laufer EM; Mingels AM; Winkens MH; Joosen IA; Schellings MW; Leiner T; Wildberger JE; Narula J; Van Dieijen-Visser MP; Hofstra L
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1269-75. PubMed ID: 20299689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Vogt W; Schömig A; Kastrati A
    Am J Cardiol; 2005 Mar; 95(5):553-7. PubMed ID: 15721090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troponin T and N-terminal pro B-Type natriuretic peptide and presence of coronary artery disease.
    Mouridsen MR; Sajadieh A; Carlsen CM; Mattsson N; Heitmann M; Nielsen OW
    Scand J Clin Lab Invest; 2015 May; 75(3):204-12. PubMed ID: 25629204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Links between sleep disordered breathing, coronary atherosclerotic burden, and cardiac biomarkers in patients with stable coronary artery disease.
    Inami T; Seino Y; Otsuka T; Yamamoto M; Kimata N; Murakami D; Takano M; Ohba T; Ibuki C; Mizuno K
    J Cardiol; 2012 Sep; 60(3):180-6. PubMed ID: 22525967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
    Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
    Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
    Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
    Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
    J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
    Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ
    Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study.
    Ivandic BT; Spanuth E; Kleber M; Grammer TB; März W
    Clin Chem Lab Med; 2011 Jun; 49(6):1053-8. PubMed ID: 21574877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Giannitsis E; Spanuth E; Horsch A; Kleber ME; Koch W; Grammer TB; Koenig W; März W
    Clin Chem Lab Med; 2013 Oct; 51(10):2019-28. PubMed ID: 24072576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
    Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
    Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.
    Palazzuoli A; Deckers J; Calabrò A; Campagna MS; Nuti R; Pastorelli M; Pasqui AL; Bruni F; Auteri A; Puccetti L
    Am J Cardiol; 2006 Nov; 98(10):1322-8. PubMed ID: 17134622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score.
    Börekçi A; Gür M; Şeker T; Baykan AO; Özaltun B; Karakoyun S; Karakurt A; Türkoğlu C; Makça I; Çaylı M
    Perfusion; 2015 Sep; 30(6):457-64. PubMed ID: 25358476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.